North American Niobium and Critical Minerals Corp. Announces Private Placement of Flow-Through Shares

Executive Summary

• North American Niobium and Critical Minerals Corp. announced a non‑brokered private placement of up to 689,655 flow‑through common shares at $1.45 per share, targeting gross proceeds of up to $1,000,000.
• Proceeds will be used to incur eligible Canadian exploration expenses in Quebec, with the company committing to renounce qualifying expenditures equal to the total amount raised by December 31 2025 and to spend them by December 31 2026.
• The offering includes finders’ fees (up to 7% of gross proceeds) and non‑transferable finders’ warrants (up to 7% of shares sold), exercisable at $1.45 per share for a 24‑month period.

Key Details

• Offering Size: Up to 689,655 flow‑through common shares (“FT Shares”).
• Price per FT Share: $1.45.
• Maximum Gross Proceeds: $1,000,000.
• Use of Proceeds: To incur eligible “Canadian exploration expenses” in Quebec that qualify as flow‑through critical mineral mining expenditures; renunciation of these expenses required by Dec 31 2025, with actual spending by Dec 31 2026.
• Finders’ Compensation:
• Fees up to 7% of gross proceeds paid to eligible finders who introduce subscribers.
• Non‑transferable finders’ warrants covering up to 7% of the number of FT Shares sold; each warrant allows purchase of one non‑flow‑through common share at $1.45 per share for 24 months from issuance.
• Closing Conditions: Subject to corporate and regulatory approvals (including CSE), no minimum subscription amount, statutory hold period of four months plus one day on all securities issued.
• CEO Quote: Murray Nye stated the financing “provides us with the resources to advance our exploration programs in Quebec in a meaningful way” and expressed confidence in strong investor interest.

Notable Quotes

“This flow‑through financing provides us with the resources to advance our exploration programs in Quebec in a meaningful way,” – Murray Nye, CEO

All forward‑looking statements are subject to risks and uncertainties; actual results may differ materially.